background: The nuclear mitotic apparatus (NuMA) plays a central role in the assembly and maintenance of spindle poles. Somatic cell nuclear transfer (SCNT) studies on non-human primates have shown that meiotic spindle removal during enucleation causes depletion of NuMA and the minus-end-directed motor protein (HSET) from the ooplasm, and this in turn leads to failure of embryo development. To determine whether NuMA from somatic cells could compensate for NuMA loss during enucleation, the distribution of NuMA and microtubule organization were investigated in human fibroblasts, developing oocytes and SCNT embryos.
Introduction
The nuclear mitotic apparatus (NuMA) protein is a high molecular weight (238 kDa) polypeptide that is located as a crescent around the spindle poles during mitosis and meiosis and translocates into the nucleus at interphase (Yang et al., 1992; Tang et al., 2004) . The NuMA molecule comprises globular head and tail domains separated by a 1500 amino-acid discontinuous coiled-coil domain (Yang et al., 1992) . NuMA has cross-linking properties that initiate spindle assembly of microtubules coincident with nuclear envelope breakdown. Additional functions attributed to NuMA include centrosome-mediated nucleation of new mitotic microtubules, as well as focusing minus-end microtubules and anchoring them to organize the spindle poles. Immunoelectron microscopy revealed that NuMA resides in a region adjacent to the centrosome, but is not directly associated with the centrosome (Maekawa et al., 1991; Tousson et al., 1991; Dionne, 1999) . NuMA plays central roles in spindle maintenance by physically tethering microtubules to centrosomes (centrosome-dependent) and by focusing spindle microtubules at the poles (centrosome-independent). These roles have been confirmed by experimental disruption of NuMA function by antibody injection or immunodepletion in extracts, which resulted in the loss of organized spindle poles (Kallajoki et al., 1991; Gaglio et al., 1995; Merdes et al., 1996) and led to chromosomal abnormality (Gordon et al., 2001) .
Despite the successful production of non-human primate embryonic stem cell (ESC) lines by somatic cell nuclear transfer (SCNT) (Byrne et al., 2007) , somatic cell cloning has not yet been accomplished in monkeys. Furthermore, the efficiency of human SCNT remains low. Although many researchers have endeavored to investigate human SCNT (Cibelli et al., 2001; Lavoir et al., 2005; Hall et al., 2007; Heindrychx et al., 2007; Fan et al., 2009) , only a few have been successful in developing SCNT blastocysts (Lu et al., 2003; Stojkovic et al., 2005; French et al., 2008; Li et al., 2009; Yu et al., 2009) in the past decade. To date, no pluripotent stem cell lines have been successfully derived from human SCNT blastocysts.
Why some species are more easily cloned and produce healthier offspring than others and what mechanisms underlie the defective development of cloned embryos are questions that have not yet been answered. NuMA and the minus-end-directed motor protein (HSET), which are vital for mitotic spindle pole formation, are removed during enucleation and are not detected in the spindles of monkey SCNT embryos (Simerly et al., 2003) . This phenomenon has been suggested to be the major reason why SCNT fails in non-human primates. But the conclusion is controversial, as another study reported normal NuMA localization and spindle formation during the first mitotic event in most monkey SCNT-produced embryos (Zhou et al., 2006) . Overall, the currently available data on NuMA and microtubules distribution in SCNT embryos are inadequate, and whether donor nucleus could bring enough NuMA protein into the oocyte to compensate the NuMA loss during enucleation is unclear.
To address these questions, in this study we observed the dynamic changes of NuMA, microtubules and chromatin in human fetal fibroblasts and developing human oocytes, and further investigated the distribution of NuMA and microtubules at the various developmental stages of human SCNT embryos, in order to gain insights into the low efficiency of human SCNT.
Materials and Methods

Patient consent and ethical approval
This study was approved and guided by the ethical committee of CITIC-XIANGYA Reproductive & Genetic Hospital. Either immature oocytes or fresh oocytes were donated for SCNT research, after obtaining written informed consent from patients undergoing infertility treatment in the ICSI or IVF programs at the CITIC-XIANGYA Reproductive & Genetic Hospital.
Isolation and culture of human fetal fibroblasts
All chemicals were purchased from Sigma-Aldrich Chemical Co. (St Louis, MO) unless otherwise stated. Primary fetal fibroblast cell lines were isolated from a 2-to 3-mm skin biopsy sample taken from fetuses from electively terminated pregnancies using standard procedures approved by the ethical committee of CITIC-XIANGYA Reproductive & Genetic Hospital. Cell lines were established and maintained in Dulbecco's modified Eagle's medium (DMEM) (high glucose) containing 10% fetal bovine serum (FBS). Passages 3 -5 of human fetal fibroblasts were used for SCNT.
Preparation of human oocytes
Immature oocytes at the germinal vesicle (GV) or metaphase I (MI) stage were obtained from ICSI therapy patients. Immature oocytes at MI were matured for 6 -8 h in G1.5 medium (Vitrolife, Sweden) supplemented with 0.075 IU/ml FSH, 0.5 IU/ml hCG and 1 mg/ml estradiol and 0.5% human serum albumin (Vitrolife). Fresh metaphase II (MII) oocytes were collected from IVF patients with polycystic ovarian syndrome undergoing puncture treatment. The oocytes were classified as GV or MI stage depending on whether or not a GV was visible. Mature oocytes were determined by the presence of a first polar body (PB), and these were exclusively used for infertility treatment.
Somatic cell nuclear transfer
Two SCNT protocols were performed. The first one is enucleation-injection (EI). Human MII oocytes were maintained in GMOPS medium supplemented with 5 mg/ml cytochalasin B for 5 -10 min before spindle removal. To guarantee accurate enucleation, the meiotic spindle was visualized based on its high birefringence, using the Ploscope Imaging System (Cambridge Research & Instrumentation Inc.), as described by Liu et al. (2000) . Then a single hole was opened in the zona pellucida at the 3 o'clock position using the ZILOS-tk Laser system (Hamilton Thorne Research, Beverly, MA, USA). The meiotic spindle and if possible, the PB were removed using an enucleation pipette [internal diameter (I.D.) 18 -20 mm]. The removal of the metaphase spindle was confirmed by its presence in the enucleation pipette. Using this innovative approach, we were able to locate and quickly remove the oocyte spindle real-time with 100% efficiency. The enucleated oocytes were incubated in cleavage medium for at least 30 min at 37.58C in 6% CO 2 in humidified air. A donor cell was drawn in and out of an injection pipette (I.D. 8 -10 mm) to break down the cell membrane. Then, donor karyoplasts were injected with a micropipette using conventional ICSI methods.
The second protocol used was injection-pronuclei enucleation (IP) (Lu et al., 2003) , which was first established in our laboratory. Briefly, a donor cell was drawn in and out of an injection pipette (I.D. 8 -10 mm) to break down the cell membrane. Then the karyoplast was injected into the cytoplasm of the oocyte at the 3 o'clock position and deposited in the oocyte near the 9 o'clock position, to maximize the distance between the donor nucleus and the PB. Artificial activation was done 2 h after injection. After activation for 6 -8 h, two pronuclear-like structures (2PN) were observed. Reconstructed embryos were cultured with 5 mg/ml cytochalasin B for 15 min, before removal of the female PN that was closer to the PB.
Two hours after reconstruction, the embryo was activated by incubation in 10 mM ionophore A23187 for 5 min. After activation, reconstructed embryos were incubated in G1.5 medium supplemented with 2 mmol/l 6-dimethylaminopurine for 4 h, then thoroughly washed in GMOPS and finally cultured in G1.5 medium under mineral oil at 37.58C, 6% CO 2 , 5% O 2 and 89% N 2 before being switched to G2.5 at Day 3. Embryos were checked for the appearance of a pronucleus (PN) between 16 and 18 h after SCNT activation and checked for the disappearance of a PN between 22 and 28 h.
Immunofluorescent confocal microscopy
After removing the zona pellucida in acidic Tyrode's buffer (pH 2.5), oocytes and reconstructed embryos were fixed for 45 min at 378C in microtubule-stabilizing buffer containing 0.1 mol/l 1,4-piperazinediethanesulfonic acid buffer (pH 6.9), 2 mmol/l MgCl 2 . 6H 2 O, 5 mmol/l EGTA, 2% formaldehyde, 0.1% Triton X-100 and 1 mmol/l taxol as previously described (Combelles et al., 2002) . A solution of 10% normal goat serum was used to block non-specific sites on the embryos for 1 h at Distribution of NuMA in human SCNT embryos room temperature or overnight at 48C, followed by an overnight incubation at 48C with a rabbit polyclonal anti-NuMA antibody (Poulson and Lechler, 2010) [Abcame, Cambridge, UK. 1:400 in phosphate-buffered saline (PBS) containing 1% bovine serum albumin (BSA)]. After three washes in PBS containing 0.1% polyvinylpyrrolidone (PBSP) for 3 min each, the embryos were labeled with goat anti-rabbit secondary antibody conjugated with Alexa fluor 594, diluted to 1:1000 in PBS-BSA for 1 h at room temperature. After extensive washing, they were incubated with a mouse anti-a-tubulin antibody (Wen et al., 2009) (1:600) overnight at 48C, washed in PBSP three times for 3 min each and incubated with fluorescein isothiocyanate-conjugated goat anti-mouse antibody (1:64) for 1 h at room temperature. Negative controls were done without the addition of primary antibody and only 1% BSA in PBS. After three washes in PBSP for 3 min each, DNA was counterstained with 4(6-diamidino-2-phenylindole) (10 mg/ml) for 8 min at room temperature and the oocytes or embryos were mounted onto glass microscope slides with anti-fade reagent (Invitrogen, CA, USA).
Digested and dispersed human fibroblasts were placed into Petri dishes containing a glass coverslip, then cultured in DMEM containing 10% FBS.
The cells were fixed with 4% paraformaldehyde in PBS (pH 7.4) for 15 min at 378C. The cells were permeabilized with 0.1% Triton X-100 in PBS for 1 h, blocked in 10% goat serum for 1 h at room temperature, then stained as described earlier. The following immunostaining steps were similar to those used for the treatment of oocytes. Immunocytochemical examination was carried out using a scanning confocal microscope (FV-1000; Olympus, Tokyo, Japan).
Results
Distribution of NuMA and a-tubulin in human fetal fibroblasts
In human fetal fibroblasts, NuMA was detected in the nucleus and a-tubulin was distributed as reticulation in the cytoplasm during interphase (Fig. 1A -D) . By prometaphase, NuMA appeared in the future spindle poles, and was located in the spindle poles in a characteristic crescent shape during metaphase (Fig. 1E-H) . However, the intensity of NuMA staining was decreased in the spindle poles during anaphase (Fig. 1I -L) and NuMA relocated to the reforming daughter cell nuclei during cytokinesis ( Fig. 1M -P) .
Distribution of NuMA and a-tubulin in human oocytes at various stages of development During the GV stage, 88.2% (15/17) of analyzed oocytes exhibit a diffused staining of NuMA in the GV bubble except in the nucleolus. Cytoplasmic microtubules were distributed around the periphery of the GV ( Fig. 2A -D) . When the GV was broken down and chromatin assembled to form chromosome clusters in pro-metaphase, NuMA was visualized as several discrete spots in the vicinity of the condensed chromosomes (100%, 25 of 25 analyzed oocytes). Aggregating microtubules were tightly associated with the condensed chromosomes ( Fig. 2E-H) . During both meiotic MI and MII stages, NuMA was relocalized to the spindle poles in 83.3% (10/12) of analyzed MI oocytes and 82.6% (19/23) of analyzed MII oocytes, ( Fig. 2I-P) . During the enucleation process under the Ploscope Imaging System, the meiotic spindle could be clearly seen in the removed cytoplast ( Fig. 3A and B) . Indirect immunofluorescent staining confirmed that NuMA and nuclei were absent from the enucleated human oocytes (Fig. 3C -F) . However, the removed cytoplast contained normal bipolar spindle poles with associated NuMA (Fig. 3G-J) .
Localization of NuMA and a-tubulin in human SCNT embryos
The efficiency of the two different SCNT methods (EI and IP) was compared. There were no significant differences between EI and IP methods in the rate of PN formation (88.9 versus 95.5%), cleavage (87.5 versus 76.2%) and blastocyst formation (8.6 versus 6.3%) ( Table I) .
Just before activation, that is at 2 h after injection of the donor cell, donor cell nuclei showed a transition to a prometaphase-like structure that appeared to be premature chromosome condensation with organized spindle in 62.5% (5/8) of the analyzed SCNT oocytes. NuMA was detected in the reformed spindle poles of 80.0% (4/5) of SCNT oocytes (Fig. 4A-D) . One pseudo-PN formed after the oocytes was activated. In 100% (11/11) of 1PN oocytes, NuMA was detected uniformly spreading across the nucleoplasm, except in the nucleolus. Cytoplasmic microtubules were distributed around the PN ( Fig. 4E-H; Fig. 5A -D) . With embryo development, 71.4% (5/7) and 60.0% (3/5) of SCNT embryos created by the EI and IP methods respectively, demonstrated that NuMA was aggregated and Distribution of NuMA in human SCNT embryos relocated to the reformed spindle poles at metaphase of the first mitotic event ( Fig. 4I -L; Fig. 5E-L) . NuMA was relocalized throughout the entire interphase nucleus in 83.3% (15/18) of SCNT embryos, when the SCNT embryos were developmentally blocked ( Fig. 4M-P ; Fig. 5M-P) .
Discussion
NuMA is a high molecular weight nuclear matrix protein first indentified and named by Lyderson and Pettyjohn (1980) . During mitosis, NuMA localizes to the vicinity of the centrosome in prophase, then to the spindle poles at metaphase and anaphase and finally relocates to the reforming nucleus at telophase. Microinjection of NuMA antibodies results in the disruption of bipolar mitotic spindles (Kallajoki et al., 1991 (Kallajoki et al., , 1993 Yang et al., 1992) . The ability of NuMA to tether microtubules at the spindle poles was shown to be essential to the formation of mitotic spindles by experiments employing in vitro immunodepletion with mitotic extracts (Compton and Cleveland, 1993; Gaglio et al., 1995; Merdes et al., 1996) . During nuclear envelope breakdown, NuMA is hyperphosphorylated by p34 cdc2 and relocates via a dyneinmediated mechanism (Merdes et al., 1996) from the former nuclear volume to the spindle poles where it remains until anaphase (Gehmlich et al., 2004) . NuMA is phosphorylated at four putative p34 cdc2 sites (threonine 2000, 2040, 2091, serine 2072) , which regulate its interaction with dynein and therefore its dynein-dependent spindle pole localization. Mutation of any of the four phosphorylated residues within this consensus sequence results in failure of NuMA to associate with the spindle poles and its subsequent targeting to the plasma membrane (Compton and Luo, 1995) . It is necessary for NuMA to relocate to poles, and NuMA phosphorylation may increase its solubility (Saredi, 1997) . The efficiency of mammalian SCNT is very low. Most cloned embryos die during post-implantation development. The survival rate to birth for cloned blastocysts is only 1-5% in most mammalian species, whereas the birth rate for IVF blastocysts is 30-60%. Furthermore, clones that survive to term are frequently defective (Cibelli et al., 2002) . SCNT of primates has proven to be more difficult than that of other species. Only one laboratory has reported success in cloning monkeys derived from embryonic blastomeres (Meng et al., 1997) , and this has not been replicated. Although monkey ESC lines derived from cloned blastocysts have been successfully produced by SCNT (Byrne et al., 2007; Sparman et al., 2009) , no successful primate reproductive cloning has been achieved despite significant efforts (Mitalipov et al., 2002; Simerly et al., 2003; Ng et al., 2004) . In non-human primates, all embryos reconstructed by SCNT displayed aberrant spindles, and NuMA and HSET were not detected in the abnormal spindles. Meiotic spindle removal depletes the ooplasm of NuMA and HSET, both of which are vital for mitotic spindle pole formation, leading to primate SCNT failures (Simerly et al., 2003) . In later experiments, NuMA was detected in most normal embryos cloned from monkeys (Zhou et al., 2006) . When transferring monkey fibroblasts into NuMA-depleted enucleated rabbit oocytes, NuMA was localized in pseudo-pronuclei and gradually moved to mitotic spindle poles at the first mitotic event (Yan et al., 2006a,b) . Since NuMA of human MII oocytes is removed along with the meiotic spindle during the enucleation process, we asked whether the loss of oocyte NuMA might cause abnormal assembly and maintenance of the spindle poles in reconstructed embryos during the first mitosis and late embryo development. Unlike in the EI SCNT method, oocyte NuMA in the IP method, which was firstly established in our laboratory (Lu et al., 2003) , remains in reconstructed embryos and contributes to PN reformation. Therefore, we compared the EI and IP SCNT methods to observe the distribution of NuMA and spindle morphology during the first mitotic event and the development efficiency of human reconstructed embryos. Here, in the first report of NuMA expression in human SCNT embryos, regardless of SCNT method used (EI or IP), we found normal spindle and NuMA expression at various developmental stages of human SCNT embryos. There were also no significant differences in development efficiency of SCNT embryos between EI and IP methods. Our results indicate that the donor cell nucleus contains NuMA that contributes to the reconstruction of embryos and maintenance of normal spindle morphology. Similar experimental results have also been shown in porcine SCNT embryos . This suggests that the low efficiency of primate SCNT is not due to the loss of NuMA during the enucleation process. 
Distribution of NuMA in human SCNT embryos
We found nuclear localization of NuMA in all stages of the cell cycle in human fetal fibroblasts. These results are consistent with those of previous studies on mouse (Zhong et al., 2005) , rat (Taimen et al., 2004) , bovine (Dai et al., 2006) , porcine (Lee et al., 2000; Zhong et al., 2005) and monkey (Yan et al., 2006a,b) cells, but not rabbit (Yan et al., 2006a,b) cells. In the rabbit model, little NuMA could be observed in interphase nuclei, but strong expression was observed after prophase. During meiotic maturation of human oocytes, NuMA was evenly spread across the nucleoplasm at the GV stage. Before GV break down (GVBD), some discrete NuMA foci were detected close to chromosomes, but most of the NuMA protein was still diffusely localized in the nucleus. After GVBD, NuMA became tightly associated with the chromosome cluster. Oocytes at MI and MII stages show NuMA localized at the spindle poles. We found that NuMA distribution in human oocytes was similar to that in pigs (Lee et al., 2000) and rabbits (Yan et al., 2006a,b) but differed from that in mice (Lee et al., 2000; Tang et al., 2004) . In mouse oocytes, NuMA was localized along the spindle microtubules (Lee et al., 2000) and at cytasters (Tang et al., 2004) . Results of this study also show that NuMA location is similar among human fibroblasts, oocytes and SCNT embryos. During the interphase of fibroblasts, oocytes and SCNT embryos, we could detect NuMA in the nucleus. Maybe NuMA is an essential structural nuclear component in human cells. During the metaphase of fibroblasts oocytes and SCNT embryos, we also detect NuMA at the spindle poles. NuMA may play an important role in spindle pole organization.
In conclusion, normal spindle and NuMA expression were found in human SCNT embryos at different developmental stages. Our results show that donor cell nuclei contain NuMA that contributed to the SCNT embryos and maintenance of normal spindle morphology.
Authors' roles X.X., X.D. and C.L. significantly contributed to the study design, execution, manuscript drafting and discussion. G.Lin and G.Lu played a key role in study design, analysis and manuscript revising. All authors contributed to the writing of the final manuscript and approved it for publication. 
